ABVC Biopharma, Inc.

The momentum for this stock is not very good. ABVC Biopharma, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in ABVC Biopharma, Inc..

News

ABVC BioPharma, Inc. (NASDAQ:ABVC) Short Interest Down 29.4% in August

Ticker Report ABVC BioPharma, Inc. (NASDAQ:ABVC - Get Free Report) was the target of a large decline in short interest in the month of August. As of August 15th, there was short interest totalling 127,200 shares...\n more…

ABVC BioPharma Releases Corporate Presentation Update

TipRanks Financial Blog An announcement from ABVC BioPharma, Inc. (ABVC) is now available. ABVC BioPharma, Inc. has recently updated its corporate presentation, details of which are not in...\n more…

Short Interest in ABVC BioPharma, Inc. (NASDAQ:ABVC) Rises By 10.4%

Ticker Report ABVC BioPharma, Inc. (NASDAQ:ABVC - Get Free Report) was the target of a significant increase in short interest during the month of July. As of July 31st, there was short interest totalling 180,200...\n more…

ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Large Increase in Short Interest

Zolmax ABVC BioPharma, Inc. (NASDAQ:ABVC - Get Free Report) was the target of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 180,200...\n more…

ABVC BioPharma reports Q2 EPS (9c) vs (68c) last year

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

ABVC BioPharma, Inc. Reports Strong Q2 2024 Financial Results and Strategic Achievements

Globe Newswire Executed Global Licensing Agreements that could provide up to $292 million in income Received Cash Milestone Incomes of $116,000 Achieved Significant Improvements in Earnings...\n more…